Serum interleukin (IL)‐1, IL‐2, sIL‐2Ra, IL‐6 and thrombopoietin levels in patients with chronic myeloproliferative diseases
Open Access
- 11 August 2005
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 130 (5), 709-715
- https://doi.org/10.1111/j.1365-2141.2005.05674.x
Abstract
A number of growth factors are involved in clonal haematopoietic expansion and their clinical significance in patients with chronic myeloproliferative diseases requires further evaluation. Using enzyme-linked immunosorbent assays, we analysed serum levels of interleukin (IL)-1a, IL-1b, IL-2, IL-6, the soluble IL-2 receptor alpha (sIL-2Ra), and thrombopoietin (TPO), in 25 individuals with myelofibrosis with myeloid metaplasia (MMM), 40 with essential thrombocythaemia (ET), eight with polycythaemia vera (PV), 10 patients with chronic myeloid leukaemia (CML) and 27 normal controls. These were correlated with clinicopathological characteristics including overall survival, and histopathological bone marrow features, including angiogenesis. The serum derived from patients with MMM, ET, PV and CML contained significantly higher IL-2 and sIL-2Ra than healthy subjects, while IL-6 levels were higher only in MMM and CML than controls. IL-2, sIL-2Ra and IL-6 levels were raised during the transformation phase of CML, during progression of MMM to AML, and ET and PV to myelofibrosis (P < 0·001). There was a positive correlation between IL-2, sIL-2Ra, IL-6 and angiogenesis in bone marrow samples. Cytokines may be useful markers for predicting clinical evolution, reflecting increased angiogenesis. This requires further evaluation to guide diagnostic and therapeutic options.Keywords
This publication has 39 references indexed in Scilit:
- Reactive and Clonal ThrombocytosisSouthern Medical Journal, 2001
- ANGIOGENESIS and ANGIOGENIC MEDIATORS IN HAEMATOLOGICAL MALIGNANCIESBritish Journal of Haematology, 2000
- Circulating interleukin‐6 levels are elevated in adult T‐cell leukaemia/lymphoma patients and correlate with adverse clinical features and survivalBritish Journal of Haematology, 1998
- Cytokines, platelet production and hemostasisPlatelets, 1997
- Megakaryocyte-Related Interleukins in Reactive Thrombocytosis versus Autonomous ThrombocythemiaActa Haematologica, 1996
- Plasma soluble interleukin‐2 receptor in patients with primary myelofibrosisBritish Journal of Haematology, 1994
- Elevated serum interleukin‐6 levels in patients with reactive thrombocytosisBritish Journal of Haematology, 1991
- Impaired interleukin‐2 production by t‐lymphocytes in polycythemia veraJournal of Clinical Laboratory Analysis, 1989
- Autocrine stimulation of interleukin 1 beta in acute myelogenous leukemia cells.The Journal of Experimental Medicine, 1987
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971